REGISTER

Register today to view and participate in our Webinar series.

Frequently Asked Questions

Click on the question and the page will jump to your answer.

What is the Somatuline^® Depot Acromegaly Answers Webinar Series?
Who can participate in the Somatuline^® Depot Acromegaly Answers Webinar Series?
Do I have to pre-register to join a Webinar session?
How do I participate in the Webinars?
What are the minimum system requirements needed in order to access the Webinars?
What types of questions can I ask during the Webinars?

What is the Somatuline^® Depot Acromegaly Answers Webinar Series?

The Somatuline^® Depot Acromegaly Answers Webinar Series is an informative and interactive series of conferences available to those who sign up to participate. Each Webinar includes a question-and-answer session. The Webinars provide practical, valuable information on a number of topics.

The Somatuline^® Depot Acromegaly Answers Webinar Series lets you see and listen to important presentations about acromegaly, and participate in discussions with experts across the nation. The Webinar series is an interactive experience between patients and experts that you may find extremely useful. Learn more about them by reading their biographies.

Who can participate in the Somatuline^® Depot Acromegaly Answers Webinar Series?

The Webinar series is open to anyone who signs up to participate. After you register, you will receive e-mail reminders about upcoming Webinar sessions.

Do I have to pre-register to join a Webinar session?

You must pre-register for the Webinar series to receive your username and password to enter each session. Your username and password will remain the same for each session, so once you register, you don’t need to register again.

How do I participate in the Webinars?

You can participate in the Somatuline^® Depot Acromegaly Answers Webinar Series as follows:

Be sure to have your username and password.
On the date and time of the Webinar, return to www.AcromegalyAnswersWebinar.com, click on the Webinars tab and click the topic link to join the session. You should log in approximately 15 minutes before the webinar is scheduled to begin.

What are the minimum system requirements needed in order to access the Somatuline^® Depot Acromegaly Answers Webinar Series?

The following system requirements are needed in order to access the Webinar online:

A computer (PC or Mac) with speakers
High-speed Internet connection (not dial-up)
Web browser (Mozilla Firefox is recommended)
Adobe Flash Player 8 or higher (Adobe Flash Player can be downloaded free of charge from Adobe.com)
For optimal viewing, set your screen resolution to 1024 x 768 or higher

What types of questions can I ask during the webinars?

You may ask any question, but please understand that not all questions can be addressed due to a high number of participants. The speakers will do their best to cover as many questions as possible. We apologize if your question is not immediately answered.

If you have a question about adverse events or side effects from treatment for acromegaly, contact your doctor immediately.

Important Indication and Safety Information

Somatuline^® Depot (lanreotide) Injection is a somatostatin analog indicated for the long-term treatment of patients with acromegaly who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy.

Lanreotide may reduce gallbladder motility and lead to gallstone formation. Periodic monitoring may be needed. Patients treated with Somatuline^® Depot (lanreotide) Injection may experience hypoglycemia or hyperglycemia. Glucose levels monitoring is recommended and antidiabetic treatment adjusted accordingly. Lanreotide may lead to a decrease in heart rate. Use with caution in at-risk patients.

Patients with moderate and severe renal impairment or moderate and severe hepatic impairment should begin treatment with Somatuline^® Depot (lanreotide) Injection 60mg.

There are no adequate and well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human responses, Somatuline^® Depot (lanreotide) Injection should be used during pregnancy only if the potential benefit justifies risk to the fetus. A decision should be made whether to discontinue nursing or discontinue the drug taking into account the importance of the drug to the mother.

Somatuline^® Depot may decrease the bioavailability of cyclosporine. Cyclosporine dose may need to be adjusted to maintain levels.

Patients receiving beta-blockers, calcium channel blockers, or other drugs that affect heart rate may need dose adjustments. Somatuline^® Depot (lanreotide) Injection may reduce the intestinal absorption of co-administered drugs. Caution should be used.

The most common adverse reactions (incidence >5%) are diarrhea, cholelithiasis, abdominal pain, nausea, injection site reaction, flatulence, arthralgia, and loose stools.

Please see Full Prescribing Information for additional important information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.